COMMUNIQUÉS West-GlobeNewswire

Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
22/02/2024
LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will [...]
Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
22/02/2024
Registration-enabling SUMMIT Part 2 initiated and actively enrolling at 40 sites globally; RP2D selected at 100 mg once-daily optimized formulation based on: 51% week 12 mean change in Total Symptom Score (TSS), [...]
Paul Johnson to run from Los Angeles to New York City in World Record attempt benefiting veterans’ nonprofit Team Red, White & Blue (Team RWB)
22/02/2024
LOS ANGELES, Feb. 22, 2024 (GLOBE NEWSWIRE) -- On March 1, 2024, Paul Johnson is commencing a life-changing challenge: running 3,000 miles across the United States from Los Angeles, CA, to New York City, N.Y. Johnson’s [...]
BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
22/02/2024
BRIGHT GREEN CORPORATION BREAKS NEW GROUND IN DOMESTIC PHARMACEUTICAL PRODUCTION GRANTS, N.M., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) company [...]
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
22/02/2024
Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors Paris, February 22, 2024 . At its meeting on February 22, 2024, Sanofi’s Board of [...]
Communiqué de presse : Le Conseil d’administration de Sanofi propose la nomination de Clotilde Delbos, Anne-Françoise Nesmes et John Sundy en qualité d’administrateurs indépendants
22/02/2024
Le Conseil d’administration de Sanofi propose la nomination de Clotilde Delbos, Anne-Françoise Nesmes et John Sundy en qualité d’administrateurs indépendants Paris, le 22 février 2024 . Lors de sa séance du 22 février [...]
MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
22/02/2024
Topline data expected in second half of 2024 THIO-101 will be the first completed clinical study of a telomere targeting agent in the field of cancer drug discovery and treatment CHICAGO, IL, Feb. 22, 2024 (GLOBE [...]
Imugene Highlights Recent Achievements and Looks Ahead to Key Upcoming Immuno-oncology Catalysts
22/02/2024
Five clinical trials across three prioritized immuno-oncology platforms with encouraging safety and efficacy signals Encouraging early results from the VAXINIA (CF33) oncolytic virus trial, including one complete [...]
Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment
22/02/2024
OMIT (Oral Mucosal Immunotherapy) is a new approach to the management of food allergy demonstrating a robust immunologic response in treated subjects NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics [...]
Team Primary Care Summit brings together primary care leaders in Canada
22/02/2024
The Foundation for Advancing Family Medicine holds a two-day summit, gathering health care experts to enhance primary care training OTTAWA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Today, the Foundation for Advancing Family [...]
Le sommet d’Équipe de soins primaires réunit les chefs de file des soins primaires au Canada
22/02/2024
La Fondation pour l’avancement de la médecine familiale organise un sommet de deux jours qui rassemble des experts de la santé afin d’améliorer la formation en soins primaires OTTAWA, 22 févr. 2024 (GLOBE NEWSWIRE) -- [...]
USOSM Partner Practices Earn “World-Class” Net Promoter Scores Year-After-Year
22/02/2024
IRVING, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Once again, U.S. Oral Surgery Management (USOSM) surgeon partners have achieved world-class Net Promoter Score™ (NPS) status, earning an overall NPS of 86 for 2023. NPS [...]
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
22/02/2024
FORT WORTH, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
22/02/2024
PRINCETON, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced the entry into a definitive agreement for [...]
ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024
22/02/2024
SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic [...]
Simple Celebrates Women-Led Science Team by Spotlighting Unique Careers for Women in STEM
22/02/2024
The nutrition and wellness company highlights the women leading the company's science and debuts a giveaway for new members LIMASSOL, Cyprus, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Simple , the nutrition and wellness app [...]
PharmAla named an Intellectual Property Ontario Client
22/02/2024
IPON to grant PharmAla an initial grant of $35,000, with a further total grant of $100,000 available in subsequent funding calls VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings [...]
Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
22/02/2024
SAN CARLOS, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]
Gracell Biotechnologies Acquisition Completed
22/02/2024
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, Nasdaq: GRCL), a global clinical-stage biopharmaceutical company developing [...]

Pages